Support Sight in the News

Bala Cynwyd, Pa. - It is estimated that 20 million Americans are now living with age-related macular degeneration (AMD) or low vision – yet, many are left in the dark about living with this devasting disease that robs precious eyesight. [...]

Novartis announced today that the US Food and Drug Administration (FDA) approved BEOVU® (brolucizumab-dbll) injection for the treatment of wet age-related macular degeneration (wet AMD). Wet AMD is caused by too much VEGF (vascular endothelial growth factor), a protein which [...]